EXPERT SPEAKER PANEL. Director, Portfolio Management Biologics Dr. Reddy s Laboratories. CEO Enrich. Executive Program Director ImmunoGen

Size: px
Start display at page:

Download "EXPERT SPEAKER PANEL. Director, Portfolio Management Biologics Dr. Reddy s Laboratories. CEO Enrich. Executive Program Director ImmunoGen"

Transcription

1 8 th Project and Portfolio Management for Pharma & Biotech Leveraging the Catalysts of Portfolio Success October 6-7, 2015 Hyatt Regency Boston Post-show report EXPERT SPEAKER PANEL CHAIRPERSON: Frank Makosiej Covance Executive Director, Operational Strategy and Planning Sean (Yong) Xue Director, Portfolio Management Biologics Dr. Reddy s Laboratories Peter Heinrich President & CEO PDWare Usman Iqbal, MD, MPH, MBA Sr. Medical Affairs Leader- ING, Global Medical Affairs AstraZeneca Richard Sonnenblick CEO Enrich Christopher Beck VP Schedule and Resource Decision Analytics Shire Karen Graham, PMP Senior Director, Project Management, Oncology Portfolio Leader Covance Julio Gagne Executive Program Director ImmunoGen Matt McLeod Senior Director, Development Team Program Lead Tesaro Frank Makosiej Executive Director, Operational Strategy and Planning Covance Sultan M. Aziz Senior Director, Head of Capacity Management Janssen Pharmaceutical Companies of Johnson & Johnson Grant Morgan SVP Portfolio Planning, Systems & Analytics BTG International Sanjeev Ramabhadran Director, Project and Portfolio Management Daiichi Sankyo Pharma Development David Townson Head, Program Office, Cell and Gene Therapies Novartis Mark Mlynarczyk Senior Director, Portfolio Operations, Strategy & Management MedImmune

2 Table of contents Page 2 Page 3 Page 4 Page 5 Table of contents About the 8th annual Key sessions of the conference + delegate breakdown Sponsor and delegate list

3 About the 8 th Annual For the eighth time, senior executives from the pharma and biotech industries gathered in October 2015 at the Hyatt Regency in downtown Boston for one of the longest-running American Leaders conferences. The speaker panel 8th Annual Project and Portfolio Management for Pharma and Biotech, chaired by Covance s Executive Director, Frank Makosiej, featured senior executives from the biggest names in the industry: including companies such as AstraZeneca, Novartis or Daiichi Sankyo. The two-day program was split into interactive sessions, providing delegates with practical solutions to the biggest issues in today s pharma PPM. Special focus was placed on strategic alignment thanks to the Building an Action Plan feature. After each session, delegates were dedicated space to work on implementing the newly-gained knowledge in their companies and to discuss strengths, weaknesses and limitations. During the two conference days, delegates discussed their opinions and shared their experience on portfolio risk management, decision-making, prescriptive modelling and data analysis for pharma portfolios, among other topics. When asked about their opinions on the event, this is what the attendees had to say: The Venue: This luxury Boston hotel features 30,000 square feet of elegant and flexible function space with innovative audiovisual equipment, hotel-wide Wi-Fi access and creative catering menus. With a combination of awardwinning service and custom amenities, Hyatt Regency Boston is the premier hotel for business travelers. The sharing of information across companies is key for the long-term health of the industry. This conference allows for a litmus test for your own company. Vincent Agresto Senior Project Associate, Program Management Systems & Operations Regeneron An incredibly insightful event and collection of industry thought leaders. Matt Killeen, PhD., Associate Director, Portfolio Strategy and Competitive Intelligence BioMarin The American Leaders meeting provided attendees with an excellent blend of actionable ideas that can be applied across many types and sizes of organizations. David Townson Executive Director, Global Program Team Director and Program Management Site Head Novartis Oncology Interesting cross-section of topics and stakeholders around the industry! Sanjeev Ramabhadran Director, Project & Portfolio Management Global Project Management & Leadership Daiichi Sankyo, Inc. The conference was initimate and ultimately informative. I, personally, have several ah-ha moments that I will take back to my company. Grant Morgan Senior Vice President, Portfolio Panning, Systems & Analytics BTG International

4 Key sessions of the 8 th Annual There were several hot topics presented and discussed in detail at the 8th Annual Project & Portfolio Management for Pharma and Biotech. Here are some of the sessions that were met with the best feedback from this year s delegates: Daiichi Sankyo s case study on examining progression of a project s viability at each stage of the life cycle Novartis presented their own tested methodology on employing micro-funding strategies to increase portfolio flexibility AstraZeneca illustrated evidence-based approaches to manage portfolio risk and prioritization in their breakout session Roundtable discussion on portfolio and resource planning integration Spotlight session on portfolio planning and execution Case study on predictive and prescriptive modeling to help drive portfolio optimization, presented by Janssen & Janssen Dedicated networking sessions with project, portfolio and resource management decision makers Job title distribution: 68% Directors/General Managers 25% Managers/Heads of Departments 7% Specialists

5 MEET OUR PARTNERS Silver Sponsors PDWare is a provider of resource planning and portfolio management software. ResourceFirst, our flagship PPM product, helps organizations improve operations through a combination of resource forecasting, capacity planning, time tracking, status reporting and financial analysis. ResourceFirst is available for cloud and on-premise installations, providing first-line managers, executives, PMOs and EPPMOs the agility to meet fluctuating work priorities, capacity and demand. PDWare customers include Medtronic, BD, Cablevision, Regeneron, SIG, Motorola, Philips, Stryker and Tektronix. Enrich was born out of a restless desire to help companies do more create more game-changing technology, develop more life-saving drugs, find more opportunity. For our clients, we build transparency into the decisions that drive their business forward. The Enrich Analytics Platform (EAP) provides the enterprise computing power; our high-touch, one-on-one approach builds the custom solutions that empower clients to make strategic business decisions and follow through on them. Media Partners

6 Company Jobtitle Country AbbVie Director, Project Office USA AbbVie Assistant Director, Planning & Portfolio Support USA Abbott Diagnostics Director, Portfolio Management USA Acetylon Pharmaceuticals Senior Director, Program Management USA Adamas Pharmaceuticals Senior Director USA Adamas Pharmaceuticals Vice President USA Aegerion Pharmaceuticals Director, Program Management USA Aegerion Pharmaceuticals Senior Director, Program Management USA Alexion Pharmaceuticals Project Manager USA Alexion Pharmaceuticals Project Planner USA Alexion Pharmaceuticals Senior Director USA Alkermes Senior Financial Analyst Ireland Alkermes Senior Director, Strategic Planning & Portfolio Management Ireland Allergan Manager, Portfolio Analysis USA Allergan Business Analytics Manager USA Amgen Manager, Strategic Planning & Operations USA Amgen Director, Pipeline Strategy & Portfolio Management USA Aptalis Pharma Senior Director, Project Management USA AstraZeneca Head, Business Operations Neuroscience USA Baxalta Senior Director, Business Operations Global Project Management USA BIND Therapeutics Project & Portfolio Professional USA BioMarin Pharmaceuticals Senior Director USA BioMarin Pharmaceuticals Senior Director USA BioMarin Pharmaceuticals Associate Director USA BioMarin Pharmaceuticals Assistant Director, Portfolio Strategy USA Boston Scientific Senior Manager, Corporate Portfolio USA CNRC-IRB Director Canada Covance Director, Portfolio Management USA Covance Senior Director, Portfolio Management USA Covidien Manager, Strategy & Portfolio USA

7 Eisai Executive Director, Global Oncology Business Unit USA Eli Lilly Advisor, Portfolio Planning USA Emergent BioSolutions Senior Director, Scientific Services USA Eureka Therapeutics Head USA Genetech Global Manager, PMO, Producer, Portfolio Management USA Genetech Cross Portfolio Governance USA Genetech Manager, Portfolio Management, USA Oncology Pipeline & Portfolio Planning Genetech Ophthalmology Franchise Lead, Pipeline & Portfolio Planning USA Genzyme Manager, Portfolio & Development Operations USA Gilead Director, Planning & Portfolio Analysis USA Gilead Associate Director USA Green Cross Corporation Deputy General Manager South Korea Green Cross Corporation Manager South Korea Grifols Head, Project Management USA Helsinn Therapeutics Manager, Project Management & Planning USA Impax Laboratories Senior Director, Portfolio Management USA Impax Laboratories Associate Director, Strategic Portfolio Management USA Integrated Project Management Business Development Executive USA Jazz Pharmaceuticals Senior Director, Project Management USA Johnson & Johnson Innovation Director USA Johnson & Johnson Innovation Global Portfolio Manager USA Juno Therapeutics Program Manager USA Juno Therapeutics Senior Director, Program/Alliance USA Life Technologies/Thermo Fisher Head, Program Management Office USA MedImmune Senior Project Manager USA Merck Associate Director USA Millenium Pharmaceuticals, Portfolio Manager USA The Takeda Oncology Company Millenium Pharmaceuticals, Director, Drug Development Manager USA The Takeda Oncology Company Novartis Executive Director USA NPS Pharmaceuticals Director, Project Management USA

8 NPS Pharmaceuticals Senior Director, Project Management USA OncoMed Pharmaceutical CMC Team Leader USA Onyx Pharmaceuticals Senior Manager USA OvaScience Associate Manager, Program Management USA Perrigo Director USA Perrigo Director, Stage Gate USA Regeneron Pharmaceuticals Director USA Regeneron Pharmaceuticals Senior Project Associate USA Roche Head, Strategy & Portfolio, Switzerland Pharma Reserach & Early Development SciClone Pharmaceuticals Assistant Project Manager USA Seattle Genetics Inc. Senior Director, Programs & Alliance Management USA Shire Pharmaceuticals Associate Director USA Smith and Nephew Senior Project Manager USA Sunovion Pharmaceuticals Associate Director USA Sunovion Pharmaceuticals Director USA Sunovion Pharmaceuticals Senior Director USA Takeda Pharmaceuticals Associate Director, Portfolio Management USA Takeda Pharmaceuticals Associate Director, Global Project Management USA & Drug Development Management Taris Biomedical Director, Program Management USA Teva Pharmaceuticals Group General Manager USA Vertex Pharmaceuticals R&D Program Manager USA Vertex Pharmaceuticals Director USA X-gen Director USA XOMA Ltd. Senior Project Manager USA XOMA Ltd. Associate Director USA XOMA Ltd. Director USA XOMA Ltd. Associate Director, Project & Alliance Management USA

6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality

6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality 6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality March 24-25, 2015 Wyndham Philadelphia Historic District, Philadelphia, PA www.exlevents.com/gcp Sponsors

More information

INCENTIVE COMPENSATION CONFERENCE

INCENTIVE COMPENSATION CONFERENCE Announcing the 2nd Annual ZS Associates INCENTIVE COMPENSATION CONFERENCE 08 September 23 24, 2008 Philadelphia, PA Incentive compensation greatly affects sales force motivation and morale. When designed

More information

CHEM-E4140 Selectivity 12. Pharma Business

CHEM-E4140 Selectivity 12. Pharma Business CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25

More information

Clinical trial research agreement Agreed schedule 4 or 7 clause amendments

Clinical trial research agreement Agreed schedule 4 or 7 clause amendments Clinical trial research agreement Agreed schedule 4 or 7 clause amendments Medicines Australia and Medical Technology Association of Australia templates The sponsors in the table have agreed clauses for

More information

Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries

Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries April 16, 2010 Oracle is currently reviewing the existing Phase Forward product roadmap and will be

More information

Orphan Pharma: pathfinders for an increasingly specialised industry

Orphan Pharma: pathfinders for an increasingly specialised industry Orphan Pharma: pathfinders for an increasingly specialised industry Foreword We are continuing our series by profiling the R&D and Clinical Development leadership of European and North American specialty

More information

The World's Top 100 Pharmaceutical Companies

The World's Top 100 Pharmaceutical Companies Brochure More information from http://www.researchandmarkets.com/reports/1878687/ The World's Top 100 Pharmaceutical Companies Description: Did you know? - Dr. Jeremy Levin is Senior Vice President, Strategy,

More information

Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019

Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics

More information

ROOT CAUSE ANALYSIS. Prevent Non-Compliance and Achieve Successful Root Cause Analyses and CAPA Systems Implementation from Clinical to Post-Market

ROOT CAUSE ANALYSIS. Prevent Non-Compliance and Achieve Successful Root Cause Analyses and CAPA Systems Implementation from Clinical to Post-Market 5th SIGNAL DETECTION, ROOT CAUSE ANALYSIS & January 22-23, 2015 Key Bridge Marriott Arlington, VA Prevent Non-Compliance and Achieve Successful Root Cause Analyses and CAPA Systems Implementation from

More information

Total Market Forecasting in Pharma USA

Total Market Forecasting in Pharma USA Third Annual Total Market Forecasting in Pharma USA Wednesday June 11 and Thursday June 12 2008, Central Philadelphia, PA, USA Forecasting success within a fast-paced and challenging industry Silver sponsor:

More information

Global Peptide Therapeutics Market 2014-2018

Global Peptide Therapeutics Market 2014-2018 Brochure More information from http://www.researchandmarkets.com/reports/3022209/ Global Peptide Therapeutics Market 2014-2018 Description: About Peptide Therapeutics Peptides are amino acids sequences

More information

ehealthinsight Series: Online Patient Recruitment Strategies

ehealthinsight Series: Online Patient Recruitment Strategies A Datamonitor report ehealthinsight Series: Online Patient Recruitment Strategies Published: May-08 Product Code: Providing you with: Overview of benefits and drawbacks of online Analysis of online patient

More information

Stakeholder Perspectives: Mild Cognitive Impairment and Dementia

Stakeholder Perspectives: Mild Cognitive Impairment and Dementia A Datamonitor In-Depth Analysis Stakeholder Perspectives: Mild Cognitive Impairment and Dementia Aricept in Race to Pioneer Unexplored Markets Published: Aug-03 Product Code: DMHC1924 Why buy this analysis?

More information

Campbell Alliance. Press Kit Materials

Campbell Alliance. Press Kit Materials Campbell Alliance Press Kit Materials Raleigh, N.C. Parsippany, N.J. Woodland Hills, Calif. South San Francisco Chicago New York City TABLE OF CONTENTS Document Page # About Campbell Alliance 3 Company

More information

Biotech Outsource Strategies

Biotech Outsource Strategies Biotech Outsource Strategies BOS Consulting BOS Events Bio2Business Ltd Key Facts Bio2Business is a leading business development organization uniquely positioned as the commercial partner of choice for

More information

Top ICT spenders in the US Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013

Top ICT spenders in the US Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013 Brochure More information from http://www.researchandmarkets.com/reports/2599260/ Top ICT spenders in the US Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013 Description: Synopsis This

More information

4 th Annual Clinical Development and Trials Asia Congress. 5 th Annual Pharma R&D World Asia Congress

4 th Annual Clinical Development and Trials Asia Congress. 5 th Annual Pharma R&D World Asia Congress Oxford Global Medical Conferences Imaging technologies are proud to present the 4 th Annual Clinical Development and Trials Asia Congress and Implementing biomarkers in co-located early phase Pharma clinical

More information

Groundbreaking Collaborative Clinical Trial Launched

Groundbreaking Collaborative Clinical Trial Launched Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)

More information

Sarah A. Haecker, PhD 1782 Humboldt Avenue Minneapolis, Minnesota 55403 612.202.6805 shaecker@celltherapygroup.com

Sarah A. Haecker, PhD 1782 Humboldt Avenue Minneapolis, Minnesota 55403 612.202.6805 shaecker@celltherapygroup.com Sarah A. Haecker, PhD 1782 Humboldt Avenue Minneapolis, Minnesota 55403 612.202.6805 shaecker@celltherapygroup.com PROFILE Successful Senior Executive, skilled in Corporate Development including Business

More information

Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus)

Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) A Datamonitor report Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) Published: Oct 07 Product Code: DMTC2133 Providing you with: Identifies which technology vendors

More information

Sixth Annual. November 18-19, 2008 Hyatt Regency at Penn s Landing Philadelphia, PA. Risk

Sixth Annual. November 18-19, 2008 Hyatt Regency at Penn s Landing Philadelphia, PA. Risk Final Agenda The Pharmaceutical Strategy Series presents Sixth Annual Strategic Resource Management Register by August 22 Save up to $700 The Key to Increasing R&D Productivity Executive Forum November

More information

How Big Data Is Hoping To Power Predictive Analytics

How Big Data Is Hoping To Power Predictive Analytics How Big Data Is Hoping To Power Predictive Analytics Date : Jun 06, 2016-07:30 AM - 10:00 AM Event URL : http:///events/how-big-data-is-hoping-to-powerpredictive-analytics-jun-2016 Organizer : New England

More information

PANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14

PANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14 PANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14 March 5-6, 2014 Princeton, NJ The Nassau Inn Identify, Prioritize and Solve Key Operational Challenges that Shape the Customer Experience in Pharma GOLD SPONSORS

More information

Pharmaceutical industry

Pharmaceutical industry 8 th March 2016 Pharmaceutical industry 2015 Global ranking strategy decisive The annual company reporting season is always an exciting period. It is an ideal time to update our industry statistics and

More information

Strategic Consulting Services

Strategic Consulting Services Services 1 Leadership Team Mark Levonyak President mlevonyak@davaonc.com Mobile: 214.460.5051 Martin W. Lee, MD EVP, Clinical Trial Services mlee@davaonc.com Mobile: 952.373.1405 John Eckardt, MD Chief

More information

Global Monoclonal Antibodies Pipeline Insight 2015

Global Monoclonal Antibodies Pipeline Insight 2015 Brochure More information from http://www.researchandmarkets.com/reports/3113388/ Global Monoclonal Antibodies Pipeline Insight 2015 Description: Ever since the Nobel Prize was bestowed on the person who

More information

The Gold Standard for Processing and Packaging

The Gold Standard for Processing and Packaging PACK EXPO Las Vegas Exhibitor Prospectus The Gold Standard for Processing and Packaging 2 O YEARS co-located with: packexpolasvegas.com/exhibit2015 A Reliable Source of Excellence When you exhibit at PACK

More information

Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct

Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct Outcomes of Monitoring Committee Reviews Medicines Australia Code of Conduct 1 Medicines Australia ABN 23 126 990 001 Level 1, 16 Napier Close Deakin ACT 2600 Phone: 02 6122 8500 Fax: 02 6122 8555 Web:

More information

The Role of Regional Medical Advisor (RMA)-Field Medical. Dr. Aju Abraham Varghese Pfizer India. Feb 22 nd 2014

The Role of Regional Medical Advisor (RMA)-Field Medical. Dr. Aju Abraham Varghese Pfizer India. Feb 22 nd 2014 The Role of Regional Medical Advisor (RMA)-Field Medical Dr. Aju Abraham Varghese Pfizer India Feb 22 nd 2014 Disclaimer The opinions expressed in this presentation are solely those of the presenter and

More information

Avoca s Quality Metrics Consulting Service Offering

Avoca s Quality Metrics Consulting Service Offering Avoca s Quality Metrics Consulting Service Offering Avoca s Quality Metrics Consulting The Challenge Biopharmaceutical companies and CROs struggle in defining how best to utilize quality metrics to optimize

More information

Due Diligence. Due Diligence Summit for Life Sciences 2 ND. Adam Muzikant. Carl Jessop Due Diligence Director, ASTRAZENECA. Alex Chang.

Due Diligence. Due Diligence Summit for Life Sciences 2 ND. Adam Muzikant. Carl Jessop Due Diligence Director, ASTRAZENECA. Alex Chang. 2 ND There has never been a conference solely dedicated to addressing the needs of due diligence and licensing professionals. As far as I m concerned, this is a must attend BUSINESS DEVELOPMENT, PFIZER

More information

The Future of Monoclonal Antibodies Therapeutics: Innovation in Antibody Engineering, Key Growth Strategies and Forecasts to 2011

The Future of Monoclonal Antibodies Therapeutics: Innovation in Antibody Engineering, Key Growth Strategies and Forecasts to 2011 Brochure More information from http://www.researchandmarkets.com/reports/344881/ The Future of Monoclonal Antibodies Therapeutics: Innovation in Antibody Engineering, Key Growth Strategies and Forecasts

More information

Cloud Marketing: Faces in the Cloud

Cloud Marketing: Faces in the Cloud Robert Groebel September 25, 2015 Features Cloud Marketing: Faces in the Cloud Share this article: facebook twitter linkedin google Comments Email Print As the need for more informed conversations with

More information

2014 CORPORATE OVERVIEW

2014 CORPORATE OVERVIEW 2014 CORPORATE OVERVIEW Applied Immunology provides custom assay services to support the development of therapeutics, vaccines and diagnostics. 2014 CORPORATE OVERVIEW 2 OUR FOCUS Applications: Immuno-oncology

More information

3:15 Networking and Refreshment Break. 3:45 Cloud Computing Manage Risk in a

3:15 Networking and Refreshment Break. 3:45 Cloud Computing Manage Risk in a 12:15 Conference Registration 1:15 Conference Chairperson s Welcome and Opening Remarks Deborah S. Turner, Associate Director, Computer and Automation Validation, Alkermes plc 1:30 Celebrating 30 Years

More information

BioPharma Analytics Informing every move

BioPharma Analytics Informing every move Specialty Solutions Insight Decisions Providers Payors Direction Patients BioPharma Analytics Informing every move Achieve market success faster with evidence-based market intelligence Cardinal Health

More information

Biopharmaceutical Raw Materials throughout the Product Lifecycle

Biopharmaceutical Raw Materials throughout the Product Lifecycle February 27 March 2, 2012 Hilton San Diego Bayfront San Diego, CA Monday Tuesday Programming: IBC s 17th International Process & Analytical Assay Validation IBC s 8th International Outsourcing Manufacturing

More information

PROVENTA INTERNATIONAL INNOVATION. Strategies for Transforming Safety, Regulatory, and Benefit-Risk Management of Established Products

PROVENTA INTERNATIONAL INNOVATION. Strategies for Transforming Safety, Regulatory, and Benefit-Risk Management of Established Products INNOVATION SPOTLIGHT SESSION Strategies for Transforming Safety, Regulatory, and Benefit-Risk Management of Established Products WEDNESDAY 4TH NOVEMBER 2015 Hyatt Regency, Princeton, NJ PROVENTA INTERNATIONAL

More information

Join our scientific talent community

Join our scientific talent community Join our scientific talent community There has never been a better time to be a part of Janssen Research & Development. We are at the forefront of healthcare leading, evolving and transforming it into

More information

2016 Sponsorship Opportunities

2016 Sponsorship Opportunities 2016 Sponsorship Opportunities 25 th Annual National Conference May 23-26, 2016 Grand America Hotel Salt Lake City UT WEDI-Con 2016 (Fall Conference) November 7-10, 2015 Hyatt Regency Reston Reston, VA

More information

Training and Employment Opportunities in the Biopharma Industry

Training and Employment Opportunities in the Biopharma Industry 014 Training and Employment Opportunities in the Biopharma Industry In association with Employment Opportunities What are the Job Opportunities in the Biopharma Industry? The strong flow of investment

More information

Biotie Therapies Corp. 4.3.2014

Biotie Therapies Corp. 4.3.2014 1 Biotie Therapies Corp. Corporate Governance Statement 2013 2 CONTENTS 1. Corporate Governance Statement 2. Board of Directors 2.1. Board composition 2.2. The operation of the Board of Directors 2.3.

More information

Medical Science Liaison (MSL): Understanding, Engaging and Interacting. Gill Logan Regional Medical Affairs Manager Takeda UK

Medical Science Liaison (MSL): Understanding, Engaging and Interacting. Gill Logan Regional Medical Affairs Manager Takeda UK Medical Science Liaison (MSL): Understanding, Engaging and Interacting Gill Logan Regional Medical Affairs Manager Takeda UK Date of upload, October 2011 Disclosures Takeda UK employee Member of the MSLA

More information

3rd Annual Patient Recruitment & Retention in Pharma

3rd Annual Patient Recruitment & Retention in Pharma Amsterdam, 23rd - 24th February 2011 3rd Annual Patient Recruitment & Retention in Pharma Who will I meet there? Chairperson Liz Moench President and CEO MediciGlobal Wolfgang Eglmeier Head Clinical Operations

More information

Biosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies

Biosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies Biosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies Fern Barkalow, Ph.D, Senior Analyst, Oncology Citeline One of the biggest challenges facing biosimilar drug developers is

More information

Annual Press Conference 2012. Business Year 2011

Annual Press Conference 2012. Business Year 2011 Business Year 2011 Highlights of the Business Year 2011 Andreas Barner Chairman of the Board of Managing Directors Corporate Board Division Pharma Research, Development and Medicine Value through Innovation

More information

The Texas Biotechnology Industry

The Texas Biotechnology Industry The Texas Biotechnology Industry 2014 Fortune 1000 company NBTY opens state-of-the-art vitamin manufacturing plant in San Antonio See Page 15 Allergan installs new production line at Waco pharmaceutical

More information

THE BIOTECH & PHARMACEUTICAL INDUSTRY

THE BIOTECH & PHARMACEUTICAL INDUSTRY THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues

More information

Blockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global

Blockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global Content Management in the Pharmaceutical Industry An Overview Blockbuster!!! Avatar USD 2 Billion revenues Lipitor USD 12.5 Billion in 2008 Dr Arun Gangatkar http://in.linkedin.com/in/drarungangatkar drarunj@gmail.com

More information

Commercial Insight Osteoarthritis and Rheumatoid Arthritis

Commercial Insight Osteoarthritis and Rheumatoid Arthritis A Datamonitor In-Depth Analysis Commercial Insight Osteoarthritis and Rheumatoid Arthritis New Growth In A Mature Market Published: Jul-03 Product Code: DMHC1891 Why buy this analysis? Target current and

More information

Transforming relationships Unleashing innovation

Transforming relationships Unleashing innovation Transforming relationships Unleashing innovation Translating Discoveries Into Products A model for innovation driven economic growth Barbara Handelin, PhD 1 The Innovation Gap Economic Opportunity Industries

More information

Bridging Clinical Trial Innovation and Quality

Bridging Clinical Trial Innovation and Quality May 13-14, 2015 (Preliminary Agenda as of April 3, 2015) Bridging Clinical Trial Innovation and Quality The Westin Princeton at Forrestal Village 201 Village Boulevard Princeton, NJ 08540 Confirmed Speakers

More information

The power of creativity www.originbranding.com. Pharmaceutical Branding 2012

The power of creativity www.originbranding.com. Pharmaceutical Branding 2012 The power of creativity www.originbranding.com Pharmaceutical Branding 2012 We are an independent, boutique agency passionately focused on developing pharmaceutical brands. For over 15 years we have delivered

More information

China Medical Equipment Market Analysis and Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015 Brochure More information from http://www.researchandmarkets.com/reports/1080808/ China Medical Equipment Market Analysis and Forecasts to 2015 Description: China Medical Equipment Market Analysis and

More information

1) SCOPE OF THE PROGRAM

1) SCOPE OF THE PROGRAM CALL FOR PROJECTS 2015/16 CANADA/GERMANY JOINT PROGRAM DEADLINE: 15 TH JANUARY 2016 1) SCOPE OF THE PROGRAM The main goal of the Canada/Germany joint program is to strengthen research in Canada and Germany

More information

Creating Joint Value. In Biopharma and Many Other Industries, Not Invented Here Is SO Last Century. By Ben Gomes-Casseres

Creating Joint Value. In Biopharma and Many Other Industries, Not Invented Here Is SO Last Century. By Ben Gomes-Casseres Creating Joint Value In Biopharma and Many Other Industries, Not Invented Here Is SO Last Century By Ben Gomes-Casseres 36 STRATEGIC ALLIANCE MAGAZINE Q3 2014 Look at any of your alliances. How do you

More information

2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit

2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit 2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit Addressing the most critical issues facing China s pharma & life science sector 10 th & 11 th April, 2014 Shanghai China

More information

Osteoporosis Drug Development Moving Forward Public Workshop

Osteoporosis Drug Development Moving Forward Public Workshop Osteoporosis Drug Development Moving Forward Public Workshop November 4, 2015 Discussion Panel Members and Speakers Robert Adler, MD Chief, Endocrinology and Metabolism McGuire Veterans Affairs Medical

More information

Investors' Access. Market. Strategic. Forum. Open. E-Health PROGRAM 2015. Alliance. Innovation PRELIMINARY. Management

Investors' Access. Market. Strategic. Forum. Open. E-Health PROGRAM 2015. Alliance. Innovation PRELIMINARY. Management OCTOBER 5-6, 2015 PARIS, FRANCE 6 th EDITION THE LEADING PARTNERING MEETING IN OPEN INNOVATION FOR LIFE SCIENCES CONFERENCES EXHIBITION HALL ONE-ON-ONE PARTNERING MEETINGS NETWORKING Open PRELIMINARY PROGRAM

More information

Biometrics: Clinical Trials and Beyond

Biometrics: Clinical Trials and Beyond Biometrics: Clinical Trials and Beyond Statistics, Programming, and Data Management in Research, Development, and Regulatory Submissions. For all, Not Just Statisticians! Keynote Presentations Sue-Jane

More information

KEEPING CLINICAL TRIALS IN AUSTRALIA

KEEPING CLINICAL TRIALS IN AUSTRALIA OCCASIONAL PAPER SERIES KEEPING CLINICAL TRIALS IN AUSTRALIA WHY ACTION IS NEEDED NOW OCCASIONAL PAPER SERIES > Medicines Australia is producing Occasional Papers to promote a contest of ideas, thought

More information

CANADA. The Premier Procurement and Strategic Sourcing Event. March 17-19th, 2014 Toronto, Canada Hyatt Regency. Event Highlights CANADA

CANADA. The Premier Procurement and Strategic Sourcing Event. March 17-19th, 2014 Toronto, Canada Hyatt Regency. Event Highlights CANADA The Premier Procurement and Strategic Sourcing Event March 17-19th, 2014 Toronto, Canada Hyatt Regency Event Highlights Don t miss our next event - See the details here! ProcureCon Canada is the premier

More information

Pharmaceutical sales in Canada have a 2.5 percent share of the global market, making th

Pharmaceutical sales in Canada have a 2.5 percent share of the global market, making th Industry Canada (/eic/site/icgc.nsf/eng/home) Home Industries and Business Canadian Life Science Industries Biopharmaceuticals and pharmaceuticals Pharmaceutical industry profile Life Science Industries

More information

Leadership for Drug Development Teams

Leadership for Drug Development Teams T U F T S C S D D P R E S E N T S Leadership for Drug Development Teams J U LY 8-9, 2014 DoubleTree by Hilton Hotel Boston, MA A leadership development opportunity with demonstrated results Create motivated,

More information

2014 EVENT HIGHLIGHTS

2014 EVENT HIGHLIGHTS 5th Annual March 23-25, 2015 The Omni San Diego, CA www.the-customer.com Achieve a single customer view, exceed customer expectations 2014 EVENT HIGHLIGHTS "A must for any company looking to establish

More information

2012 National BDPA Technology Conference. Defining Project and PMO Metrics

2012 National BDPA Technology Conference. Defining Project and PMO Metrics 2012 National BDPA Technology Conference Defining Project and PMO Metrics Betty Hutchins, MBA, PMP August 1 4, 2012 Baltimore, MD Presentation Objectives Project Performance Determine the Process Defining

More information

How Global Data Management (GDM) within J&J Pharma is SAVE'ing its Data. Craig Pusczko & Chris Henderson

How Global Data Management (GDM) within J&J Pharma is SAVE'ing its Data. Craig Pusczko & Chris Henderson How Global Data Management (GDM) within J&J Pharma is SAVE'ing its Data Craig Pusczko & Chris Henderson Abstract See how J&J Pharma organizational alignment drove the evolution of Global Data Management

More information

Stakeholder Insight: Insulin Use in Type 2 Diabetes

Stakeholder Insight: Insulin Use in Type 2 Diabetes A Datamonitor Report Stakeholder Insight: Insulin Use in Type 2 Diabetes From Last Resort to Early Intervention Published: May-04 Product Code: DMHC1989 Providing you with: Analysis of Datamonitor s Diabetes

More information

Published by Waterford Life Sciences, Washington, DC 202-299-0600 Cover and book design: Gretchen Maxwell, GLM Design

Published by Waterford Life Sciences, Washington, DC 202-299-0600 Cover and book design: Gretchen Maxwell, GLM Design Copyright 2007 Scott M. Fishman, MD CME Activity Copyright 2009 The University of Wisconsin Board of Regents Published by Waterford Life Sciences, Washington, DC 202-299-0600 Cover and book design: Gretchen

More information

Acknowledgements. We thank these organizations and individuals for their unrestricted support.

Acknowledgements. We thank these organizations and individuals for their unrestricted support. Power to the People Presented by Dawn Richards, PhD, Person with Rheumatoid Arthritis Arthritis Consumer Experts Advisory Board Member Canadian Arthritis Patient Alliance Vice President Acknowledgements

More information

Notice of Annual General Meeting

Notice of Annual General Meeting Basel, February 3, 2014 To the shareholders of Novartis AG Notice of Annual General Meeting Date: Tuesday, February 25, 2014, 10.00 a.m. (doors open at 8.30 a.m.) Place: St. Jakobshalle, Basel (entrance

More information

IDC US UPCOMING EVENT CALENDAR

IDC US UPCOMING EVENT CALENDAR IDC US UPCOMING EVENT CALENDAR Software as a Service (SaaS) Summit Contact: Patty Caron, Program Director, pcaron@idc.com Lead Analysts: Michael Fauscette and Robert P. Mahowald September 17, 2008 San

More information

Lilly Covance Strategic Alliance From Vision to Results. Adrienne Takacs, PhD Jonathan Koch, MBA

Lilly Covance Strategic Alliance From Vision to Results. Adrienne Takacs, PhD Jonathan Koch, MBA Lilly Covance Strategic Alliance From Vision to Results Adrienne Takacs, PhD Jonathan Koch, MBA Topics 1. Lilly s Challenge... a Partnership Opportunity 2. Our Landmark Agreement 3. A Local Success Story

More information

Life Sciences Outlook. New Jersey 2015

Life Sciences Outlook. New Jersey 2015 Life Sciences Outlook New Jersey 2015 New Jersey M&A activity in New Jersey has led to the consolidation of surplus real estate holdings and diminished head counts. However, midsized companies are helping

More information

Digital Leaders Deal With a Range of Organizational Challenges

Digital Leaders Deal With a Range of Organizational Challenges May 22, 2014 OVERCOMING OBSTACLES TO DIGITAL TRANSFORMATION SUCCESS IN THE PHARMACEUTICAL INDUSTRY Digital Leaders Deal With a Range of Organizational Challenges by Tim van Tongeren with Dennis van Rooij

More information

Evaluating Business Intelligence Opportunities in the Pharmaceutical Industry (Strategy Focus)

Evaluating Business Intelligence Opportunities in the Pharmaceutical Industry (Strategy Focus) STRATEGY FOCUS Evaluating Business Intelligence Opportunities in the Pharmaceutical Industry (Strategy Focus) A strategic sales model for BI solutions in Big Pharma and Biotech Reference Code: BFTC1675

More information

Rising importance of Business Analysis when performing projects

Rising importance of Business Analysis when performing projects Rising importance of Business Analysis when performing projects A state-of-the-art view on Business Analysis HJB Getting in Control Your Presenter More than 30 years experience in project/program/portfolio

More information

JOHN REID PhD, MBA. (302) 544-1743 entrepidbd@gmail.com http://www.linkedin.com/in/jdreid1

JOHN REID PhD, MBA. (302) 544-1743 entrepidbd@gmail.com http://www.linkedin.com/in/jdreid1 JOHN REID PhD, MBA (302) 544-1743 entrepidbd@gmail.com http://www.linkedin.com/in/jdreid1 PROFILE Senior-level business development and licensing executive with a well-honed ability to translate scientific

More information

Profile of Biomedical Research and Biotechnology Commercialization. Los Angeles-Riverside-Orange County Consolidated Metropolitan Statistical Area

Profile of Biomedical Research and Biotechnology Commercialization. Los Angeles-Riverside-Orange County Consolidated Metropolitan Statistical Area Profile of Biomedical Research and Biotechnology Commercialization Los Angeles-Riverside-Orange County Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in Los Angeles Los

More information

June 28-29 Washington, DC SPONSORSHIP OPPORTUNITIES

June 28-29 Washington, DC SPONSORSHIP OPPORTUNITIES June 28-29 Washington, DC SPONSORSHIP OPPORTUNITIES OVERVIEW Due rising out-of-pocket consumer healthcare costs, the recently passed healthcare reform legislation, and new technology innovation, the healthcare

More information

The Linux Foundation and Its Event Production

The Linux Foundation and Its Event Production LINUX FOUNDATION EVENT SERVICES Leverage our knowledge of events and open source to ensure your next event is a success. Take advantage of our experience producing events around the world and our knowledge

More information

BIOTECHNOLOGY. Bouvé College of Health Sciences College of Science. Networked for Success. Networked for Industry. Networked for Life.

BIOTECHNOLOGY. Bouvé College of Health Sciences College of Science. Networked for Success. Networked for Industry. Networked for Life. MASTER OF SCIENCE BIOTECHNOLOGY Networked for Success. Networked for Industry. Networked for Life. Bouvé College of Health Sciences College of Science Northeastern s Biotechnology Masters program synthesizes

More information

Governance. Execution. Value.

Governance. Execution. Value. September 21-22, 2015 Hyatt Regency Toronto, Ontario Governance. Execution. Value. The Premier Reference Data, Counterparty Risk and Data Innovation Conference Donna Rudnicki Chief Data Officer RBC Capital

More information

How To Understand And Understand Biosimilars

How To Understand And Understand Biosimilars Welcome to Biosimilars 20/20, presented by the Specialty Pharma Education Center (SPEC) in partnership with the Specialty Pharma Journal (SPJ). Please note that this is a preliminary agenda that is subject

More information

sponsorship and exhibitor prospectus July 25-26, 2016 seaport boston Boston, MA

sponsorship and exhibitor prospectus July 25-26, 2016 seaport boston Boston, MA mhealth + TELEHEALTH World 2 016 strategies for implementing, sustaining, and expanding connected health programs to capture roi July 25-26, seaport boston Boston, MA sponsorship and exhibitor prospectus

More information

THE VIRAL HEPATITIS CONGRESS 2015. 10 12 September 2015, Kap Europa, Frankfurt, Germany THE VIRAL HEPATITIS CONGRESS. Scientific Programme

THE VIRAL HEPATITIS CONGRESS 2015. 10 12 September 2015, Kap Europa, Frankfurt, Germany THE VIRAL HEPATITIS CONGRESS. Scientific Programme THE VIRAL HEPATITIS CONGRESS THE VIRAL HEPATITIS CONGRESS 2015 10 12 September 2015, Kap Europa, Frankfurt, Germany Scientific Programme PRE-CONGRESS WORKSHOP SPONSOR ACHILLION Achillion is seeking to

More information

Partnering for scientific leadership

Partnering for scientific leadership Partnering for scientific leadership AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily

More information

M&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends

M&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends M&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends Symposium Life Science am Kapitalmarkt Frankfurt, 3. Juni 28 Global biotech industry Strong growth in most areas but Visible product

More information

FOR SUCCESS YOUR PRESCRIPTION SPEAK. Business

FOR SUCCESS YOUR PRESCRIPTION SPEAK. Business YOUR PRESCRIPTION FOR SUCCESS Georgia is on the pulse of bioscience. After all, the industry has a $7.5 billion impact on our GDP and employs more than 70,000 people in our state. Find out why 300-plus

More information

Life Sciences Outlook. Philadelphia 2015

Life Sciences Outlook. Philadelphia 2015 Life Sciences Outlook Philadelphia 2015 Philadelphia Booming eds & meds, big pharma, more startups: Philadelphia s market fundamentals are strong, thanks to a diverse ecosystem of established pharma firms

More information

PMI Mass Bay Chapter Call for Speakers

PMI Mass Bay Chapter Call for Speakers Chapter Call for Speakers Project Management Project Management Trends and Best Practices Four Points by Sheraton Norwood Hotel and Conference Center 1125 Boston Providence Turnpike Norwood, MA 02062 PMI

More information

Accelerating Drug & Clinical Trial Approvals in China & East Asia

Accelerating Drug & Clinical Trial Approvals in China & East Asia 25 28 March 2014 The Westin Beijing Chaoyang, Accelerating Drug & Clinical Trial Approvals in & East Asia What s New in 2014? Key Regulatory Update from the National Institute for Food & Drug Control,

More information

Health Reform s New Frontier: Balancing Cost, Value and Innovation

Health Reform s New Frontier: Balancing Cost, Value and Innovation Health Reform s New Frontier: Balancing Cost, Value and Innovation A panel discussion Genzyme Corporation Cambridge, MA February 23, 2010 Welcome from NEHI s President NEHI Members and Friends: In this

More information

TRENDS SHAPING THE FUTURE OF PERSONALIZED CARE AND THE DELIVERY OF SPECIALTY PHARMACY

TRENDS SHAPING THE FUTURE OF PERSONALIZED CARE AND THE DELIVERY OF SPECIALTY PHARMACY TRENDS SHAPING THE FUTURE OF PERSONALIZED CARE AND THE DELIVERY OF SPECIALTY PHARMACY Key Takeaways from the June 18, 2013 Regional Symposium Nashville, Tennessee THE SYMPOSIUM Trends Shaping the Future

More information

Biopharmaceutical Raw Materials throughout the Product Lifecycle. Biosimilars and Biobetters Development & Production. www.ibclifesciences.

Biopharmaceutical Raw Materials throughout the Product Lifecycle. Biosimilars and Biobetters Development & Production. www.ibclifesciences. Monday Tuesday Programming: Wednesday Friday Programming: IBC s 18th International Process Validation, Monitoring & Control Supply Chain Management for Biopharmaceuticals Cold Chain Logistics and Distribution

More information

Profile of Biomedical Research and Biotechnology Commercialization. Boston-Worcester-Lawrence Consolidated Metropolitan Statistical Area

Profile of Biomedical Research and Biotechnology Commercialization. Boston-Worcester-Lawrence Consolidated Metropolitan Statistical Area Profile of Biomedical Research and Biotechnology Commercialization Boston-Worcester-Lawrence Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in Boston Along with San Francisco,

More information

Biomanufacturing Vision for the Future

Biomanufacturing Vision for the Future Biomanufacturing Vision for the Future Shou-Bai Chao, Ph.D. Senior Vice President Global Manufacturing and Technical Operations MedImmune (a Div of AstraZeneca) NIPTE/FDA Research Conference Future of

More information

CONFERENCE PROGRAMME D R I V I N G Success ACDM Annual Conference 2010

CONFERENCE PROGRAMME D R I V I N G Success ACDM Annual Conference 2010 CONFERENCE PROGRAMME PHOTO: MARK MCARDLE, CANADA DRIVING Whittlebury Hall Hotel, Northamptonshire 21st-23rd March DAY 1 09:00 Welcome Speech Tracy Fells, Head of Data Management Operations (Europe), CMED

More information

Rx-360 An International Pharmaceutical Supply Chain Consortium

Rx-360 An International Pharmaceutical Supply Chain Consortium Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011 Rx-360 Members (Continuously updated list at www.rx-360.org) Manufacturers (24)

More information

Project Management Excellence in Life Sciences: Balancing Art and Science

Project Management Excellence in Life Sciences: Balancing Art and Science THE E DIA PROJECT MANAGEMENT SIAC AND PMI PHARMACEUTICAL SIG PRESENT: Project Management Excellence in Life Sciences: Balancing Art and Science October 23-24, 2008 Marriott Wardman Park Hotel, Washington,

More information